$0.735

0.025 (3.52%)

Want access to our research and new buy ideas?

Take a free 15 day trial - no credit card required.

Start your free trial now

General Information

AirXpanders, Inc.
AXP
http://www.airxpanders.com
Health Care Equipment
204
288

Current Price Data+

Current Price $0.735
Open $0.700
High $0.740
Low $0.700
Last Close $0.710
Volume 27364
Price Movement $0.03 ( 3.52% )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

Company Overview

Business Description

AirXpanders, Inc (AXP) is a US based company focused on the design, manufacturing, sale and distribution of its AeroForm tissue expander for breast reconstruction procedures following mastectomy. It was founded with the purpose of developing a better method for breast tissue expansion than traditional saline tissue expanders.

Financial Summary

Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2016 A -26.8 -35.9 0.0% 0.0 0.0 0.0% 0.0%
2015 A -11.2 -5.3 0.0% 0.0 0.0 0.0% 0.0%
2014 A 0.0 0.0 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2014 A 2015 A 2016 A 2014 A 2015 A 2016 A 2014 A 2015 A 2016 A
AirXpanders (AXP) $201M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Cochlear (COH) $10,423M 0.1790 0.1128 0.1507 46.5510 41.8333 36.3532 1.49% 1.71% 1.93%
Fisher & Paykel Hlth (FPH) $6,961M 0.3370 -0.0162 0.2075 40.3573 41.0222 33.9738 1.46% 1.70% 2.06%
Impedimed (IPD) $361M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed (RMD) $15,848M -0.2434 0.0000 0.0000 43.1783 0.0000 0.0000 1.56% 0.00% 0.00%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 9.93 0.00
Market 1.02 15.50 1.56 1.16
Sector 1.21 20.10 2.40 2.28

Directors

Name Position Start Date
Mr Barry Cheskin Non-Executive Chairman, Non-Executive Director 29 Dec 2006
Ms Zita Peach Non-Executive Director 17 May 2016
Mr Dennis Edward Condon Non-Executive Director 1 Aug 2012
Mr Gregory Lichtwardt Non-Executive Director 17 May 2016
Ms Elizabeth Hammack Non-Executive Director 23 May 2017
Mr Scott Allen Dodson President, Chief Executive Officer, Executive Director 22 Oct 2010

Management

Name Position
Kirsty Amland Business Director, Asia Pacific
Scott Murcray Chief Financial Officer,Chief Operating Officer
Brendan Case Company Secretary
Kathy Kelley Senior Director, Clinical Affairs
Jennie Kim Senior Director, Global Marketing
Gwen Drain Senior Director, Human Resources
Mark Payne Senior Director, Research & Development
Tony Morefield VP of Operations
Anthony Carnemolla VP of Sales

Substantial Shareholders

Holding Name
80,492,554 (28%) Citicorp Nominees Pty Limited
50,526,477 (17.60%) Vivo
44,804,359 (15.60%) GBS Venture Partners Pty Ltd as Trustee for the GBS Bioventures IV Trust
30,258,846 (10.50%) J P Morgan Nominees Australia Limited
20,061,877 (6.90%) Prolog Capital II, L.P.
16,902,205 (5.90%) Regal Funds Management Pty Limited
14,823,214 (5.20%) National Nominees Ltd
14,628,151 (5.10%) Ubs Nominees Pty Ltd

Calendar of Events

Date Event
09 August 2018 Report (Interim)
29 March 2018 Report (Annual)
27 February 2018 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.